Subscribe to RSS
DOI: 10.1055/s-0041-111519
Postoperatives Leberversagen nach erweiterten Leberresektionen – eine Übersicht, gestützt durch eine retrospektive Single-Center-Analyse
Posthepatectomy Liver Failure in Extended Liver Resections: An Overview Based on a Retrospective Single-Centre AnalysisPublication History
Publication Date:
02 May 2016 (online)
Zusammenfassung
Hintergrund: Postoperatives Leberversagen (PHLF) ist eine der schwerwiegendsten Komplikationen nach größeren Leberresektionen und ein wichtiger Faktor in Bezug auf die perioperative Morbidität und Mortalität. Trotz vieler Fortschritte im Verständnis und der Abstufung des PHLF existieren in der Literatur äußerst heterogene Definitionen, was eine Identifikation von Hochrisikopatienten erschwert. In dieser Studie analysierten wir die Ergebnisse erweiterter Leberresektionen und potenzieller Risikofaktoren für PHLF basierend auf Patientendaten eines Universitätsklinikums. Ziel der Untersuchung war es, einen Überblick der wesentlichen Aspekte in der Vermeidung des PHLFs in Verbindung mit intraoperativen Kernpunkten und einer optimierten postoperativen Behandlung zu entwickeln. Methoden: Daten von 202 Patienten, die sich einer großen, elektiven Leberresektion an einem Universitätsklinikum zwischen 04/1989 und 09/2009 unterzogen, wurden analysiert (135 Hemihepatektomien rechts, 39 Hemihepatektomien links, 28 erweiterte Hemihepatektomien rechts). Nach Balzan et al. „50/50-criteria“ wurde PHLF definiert als Quick < 50 % und Serumbilirubin > 50 µmol/l am postoperativen Tag 5 (POD 5) oder als Tod durch primäres oder sekundäres Leberversagen. Ergebnisse: Die 30-Tage-Mortalität und die Gesamtkrankenhausmortalität betrugen 4,95 bzw. 8,91 %. 28 (14 %) Patienten entwickelten ein PHLF, von denen 16 (57 %) verstarben. Im Vergleich zu den Patienten mit normaler postoperativer Leberfunktion waren mehrere prä- und intraoperative Faktoren in beiden Gruppen signifikant unterschiedlich: z. B. primäres Lebermalignom (p < 0,001), erweiterte Leberresektion (p < 0,001), OP-Dauer (p < 0,001) und Notwendigkeit zur intraoperativen Transfusion von Erythrozytenkonzentraten (p < 0,02) oder gefrorenen Frischplasmen (p < 0,001). Schlussfolgerung: Obwohl Fortschritte in der Hepatobiliärchirurgie zu verzeichnen sind, bleibt das PHLF eine ernsthafte Komplikation, insbesondere bei Patienten mit erweiterten Leberresektionen. Eine sorgfältige und optimierte präoperative Risikostratifizierung ist erforderlich, um Hochrisikopatienten für PHLF vorab zu identifizieren.
Abstract
Background: Posthepatectomy liver failure (PHLF) is one of the most serious complications after major liver resections and an important factor in terms of perioperative morbidity and mortality. Despite many advances in the understanding and grading of PHLF, the definitions found in literature are very heterogeneous, which complicates the identification of high-risk patients. In this study we analysed the results of extended liver resections and potential risk factors for PHLF based on patient data derived from our tertiary referral centre. The aim of the study was to gain an overview of the essential aspects in the prevention of PHLF combined with key intraoperative issues and postoperative treatment strategies. Methods: We analysed data from 202 patients who underwent extended elective liver resections at our centre between April 1989 and September 2009 (135 right hemihepatectomies, 39 left hemihepatectomies, 28 right trisectionectomies). According to Balzanʼs “50/50 criteria”, PHLF was defined as prothrombin time (PT) < 50 % combined with serum bilirubin (SB) > 50 micromol/L on postoperative day (POD) 5 or as death due to primary or secondary liver failure. Results: Thirty-day mortality and overall in-hospital mortality were 4.95 and 8.91 %, respectively. Twenty-eight (14 %) patients developed PHLF and 16 (57 %) patients died. Compared to patients with normal postoperative liver function, several significant pre- and intraoperative factors for PHLF were identified, e.g. primary malignant liver tumour (p < 0.001), extended liver resection (p < 0.001), time of surgery (p < 0.001) and intraoperative transfusion of packed RBC (p < 0.02) or FFP (p < 0.001). Conclusion: Although progress has been made in hepatobiliary surgery, PHLF remains a serious complication, especially after extended liver resections. Careful, optimised preoperative risk stratification is required to identify patients at risk for PHLF.
-
Literatur
- 1 Heise M, Jandt K, Rauchfuss F et al. [Management of complications after liver resection]. Zentralbl Chir 2010; 135: 112-120
- 2 Erdogan D, Busch OR, Gouma DJ et al. Morbidity and mortality after liver resection for benign and malignant hepatobiliary lesions. Liver Int 2009; 29: 175-180
- 3 Lock JF, Malinowski M, Seehofer D et al. Function and volume recovery after partial hepatectomy: influence of preoperative liver function, residual liver volume, and obesity. Langenbecks Arch Surg 2012; 397: 1297-1304
- 4 Stockmann M, Lock JF, Riecke B et al. Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Ann Surg 2009; 250: 119-125
- 5 Lock JF, Reinhold T, Malinowski M et al. The costs of postoperative liver failure and the economic impact of liver function capacity after extended liver resection–a single-center experience. Langenbecks Arch Surg 2009; 394: 1047-1056
- 6 Balzan S, Belghiti J, Farges O et al. The “50-50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 2005; 242: 824-828
- 7 Strasberg SM. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg 2005; 12: 351-355
- 8 Strasberg SM, Phillips C. Use and dissemination of the brisbane 2000 nomenclature of liver anatomy and resections. Ann Surg 2013; 257: 377-382
- 9 Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213
- 10 Foster JH, Berman MM. Solid liver tumors. Major Probl Clin Surg 1977; 22: 1-342
- 11 Jarnagin WR, Gonen M, Fong Y et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002; 236: 397-406
- 12 Reddy SK, Barbas AS, Turley RS et al. A standard definition of major hepatectomy: resection of four or more liver segments. HPB (Oxford) 2011; 13: 494-502
- 13 Schroeder RA, Marroquin CE, Bute BP et al. Predictive indices of morbidity and mortality after liver resection. Ann Surg 2006; 243: 373-379
- 14 Benzoni E, Lorenzin D, Baccarani U et al. Resective surgery for liver tumor: a multivariate analysis of causes and risk factors linked to postoperative complications. Hepatobiliary Pancreat Dis Int 2006; 5: 526-533
- 15 Mullen JT, Ribero D, Reddy SK et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 2007; 204: 854-862
- 16 Breitenstein S, DeOliveira ML, Raptis DA et al. Novel and simple preoperative score predicting complications after liver resection in noncirrhotic patients. Ann Surg 2010; 252: 726-734
- 17 Andres A, Toso C, Moldovan B et al. Complications of elective liver resections in a center with low mortality: a simple score to predict morbidity. Arch Surg 2011; 146: 1246-1252
- 18 Paugam-Burtz C, Janny S, Delefosse D et al. Prospective validation of the “fifty-fifty” criteria as an early and accurate predictor of death after liver resection in intensive care unit patients. Ann Surg 2009; 249: 124-128
- 19 Rahbari NN, Garden OJ, Padbury R et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 2011; 149: 713-724
- 20 Schreckenbach T, Liese J, Bechstein WO et al. Posthepatectomy liver failure. Dig Surg 2012; 29: 79-85
- 21 Koea J. Getting started as a hepatobiliary surgeon: lessons learned from the first 100 hepatectomies as a consultant. N Z Med J 2005; 118: U1322
- 22 Karoui M, Penna C, Amin-Hashem M et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006; 243: 1-7
- 23 Virani S, Michaelson JS, Hutter MM et al. Morbidity and mortality after liver resection: results of the patient safety in surgery study. J Am Coll Surg 2007; 204: 1284-1292
- 24 van den Broek MA, Olde Damink SW, Dejong CH et al. Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int 2008; 28: 767-780
- 25 Hsu KY, Chau GY, Lui WY et al. Predicting morbidity and mortality after hepatic resection in patients with hepatocellular carcinoma: the role of Model for End-Stage Liver Disease score. World J Surg 2009; 33: 2412-2419
- 26 Huang ZQ, Xu LN, Yang T et al. Hepatic resection: an analysis of the impact of operative and perioperative factors on morbidity and mortality rates in 2008 consecutive hepatectomy cases. Chin Med J (Engl) 2009; 122: 2268-2277
- 27 Tzeng CW, Cooper AB, Vauthey JN et al. Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients. HPB (Oxford) 2014; 16: 459-468
- 28 Teh SH, Sheppard BC, Schwartz J et al. Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis. Am J Surg 2008; 195: 697-701
- 29 Huang L, Li J, Yan JJ et al. Prealbumin is predictive for postoperative liver insufficiency in patients undergoing liver resection. World J Gastroenterol 2012; 18: 7021-7025
- 30 Jin S, Fu Q, Wuyun G et al. Management of post-hepatectomy complications. World J Gastroenterol 2013; 19: 7983-7991
- 31 Clavien PA, Petrowsky H, DeOliveira ML et al. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007; 356: 1545-1559
- 32 Hoekstra LT, de Graaf W, Nibourg GA et al. Physiological and biochemical basis of clinical liver function tests: a review. Ann Surg 2013; 257: 27-36
- 33 Stockmann M, Lock JF, Malinowski M et al. The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB (Oxford) 2010; 12: 139-146
- 34 Pulitano C, Crawford M, Joseph D et al. Preoperative assessment of postoperative liver function: the importance of residual liver volume. J Surg Oncol 2014; 110: 445-450
- 35 Cescon M, Colecchia A, Cucchetti A et al. Value of transient elastography measured with FibroScan in predicting the outcome of hepatic resection for hepatocellular carcinoma. Ann Surg 2012; 256: 706-712
- 36 Selzner N, Rudiger H, Graf R et al. Protective strategies against ischemic injury of the liver. Gastroenterology 2003; 125: 917-936
- 37 Hoekstra LT, van Trigt JD, Reiniers MJ et al. Vascular occlusion or not during liver resection: the continuing story. Dig Surg 2012; 29: 35-42
- 38 Mise Y, Sakamoto Y, Ishizawa T et al. A worldwide survey of the current daily practice in liver surgery. Liver Cancer 2013; 2: 55-66
- 39 Richardson AJ, Laurence JM, Lam VW. Portal triad clamping versus other methods of vascular control in liver resection: a systematic review and meta-analysis. HPB (Oxford) 2012; 14: 355-364
- 40 Vaid A, Chweich H, Balk EM et al. Molecular adsorbent recirculating system as artificial support therapy for liver failure: a meta-analysis. ASAIO J 2012; 58: 51-59
- 41 van den Broek MA, van Dam RM, Malago M et al. Feasibility of randomized controlled trials in liver surgery using surgery-related mortality or morbidity as endpoint. Br J Surg 2009; 96: 1005-1014